- call +1-201-465-4211
- email sales@mrinsights.biz
Certolizumab pegol is a TNF (tumor necrosis factor) inhibitor that is primarily used to treat Crohns disease. Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha (TNF-alfa). In 2008, it was approved for rheumatoid arthritis treatment under the brand CIMZIA®. It was used off-label to treat psoriatic arthritis until it was approved for this indication in 2013.
Scope of the Report:
This report focuses on the Cimzia (certolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Cimzia (certolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
UCB
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Crohn's Disease
Rheumatoid Arthritis
Market Segment by Applications, can be divided into
Crohn's Disease
Rheumatoid Arthritis
There are 15 Chapters to deeply display the global Cimzia (certolizumab) Drug market.
Chapter 1, to describe Cimzia (certolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cimzia (certolizumab) Drug, with sales, revenue, and price of Cimzia (certolizumab) Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cimzia (certolizumab) Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cimzia (certolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cimzia (certolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cimzia (certolizumab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Crohn's Disease
1.2.2 Rheumatoid Arthritis
1.3 Market Analysis by Applications
1.3.1 Crohn's Disease
1.3.2 Rheumatoid Arthritis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 UCB
2.1.1 Business Overview
2.1.2 Cimzia (certolizumab) Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 UCB Cimzia (certolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cimzia (certolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cimzia (certolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cimzia (certolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cimzia (certolizumab) Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Cimzia (certolizumab) Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cimzia (certolizumab) Drug Market Analysis by Regions
4.1 Global Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Cimzia (certolizumab) Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cimzia (certolizumab) Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
4.3 Europe Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
4.5 South America Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
5 North America Cimzia (certolizumab) Drug by Countries
5.1 North America Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Cimzia (certolizumab) Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cimzia (certolizumab) Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
5.3 Canada Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
6 Europe Cimzia (certolizumab) Drug by Countries
6.1 Europe Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Cimzia (certolizumab) Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cimzia (certolizumab) Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
6.3 UK Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
6.4 France Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
6.5 Russia Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
6.6 Italy Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cimzia (certolizumab) Drug by Countries
7.1 Asia-Pacific Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cimzia (certolizumab) Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cimzia (certolizumab) Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
7.3 Japan Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
7.4 Korea Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
7.5 India Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
8 South America Cimzia (certolizumab) Drug by Countries
8.1 South America Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Cimzia (certolizumab) Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cimzia (certolizumab) Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cimzia (certolizumab) Drug by Countries
9.1 Middle East and Africa Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cimzia (certolizumab) Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cimzia (certolizumab) Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
9.3 UAE Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Cimzia (certolizumab) Drug Sales and Growth Rate (2013-2018)
10 Global Cimzia (certolizumab) Drug Market Segment by Type
10.1 Global Cimzia (certolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cimzia (certolizumab) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Cimzia (certolizumab) Drug Revenue and Market Share by Type (2013-2018)
10.2 Crohn's Disease Sales Growth and Price
10.2.1 Global Crohn's Disease Sales Growth (2013-2018)
10.2.2 Global Crohn's Disease Price (2013-2018)
10.3 Rheumatoid Arthritis Sales Growth and Price
10.3.1 Global Rheumatoid Arthritis Sales Growth (2013-2018)
10.3.2 Global Rheumatoid Arthritis Price (2013-2018)
11 Global Cimzia (certolizumab) Drug Market Segment by Application
11.1 Global Cimzia (certolizumab) Drug Sales Market Share by Application (2013-2018)
11.2 Crohn's Disease Sales Growth (2013-2018)
11.3 Rheumatoid Arthritis Sales Growth (2013-2018)
12 Cimzia (certolizumab) Drug Market Forecast (2018-2023)
12.1 Global Cimzia (certolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Cimzia (certolizumab) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Cimzia (certolizumab) Drug Market Forecast (2018-2023)
12.2.2 Europe Cimzia (certolizumab) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cimzia (certolizumab) Drug Market Forecast (2018-2023)
12.2.4 South America Cimzia (certolizumab) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cimzia (certolizumab) Drug Market Forecast (2018-2023)
12.3 Cimzia (certolizumab) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Cimzia (certolizumab) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Cimzia (certolizumab) Drug Market Share Forecast by Type (2018-2023)
12.4 Cimzia (certolizumab) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Cimzia (certolizumab) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Cimzia (certolizumab) Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cimzia (certolizumab) Drug Picture
Table Product Specifications of Cimzia (certolizumab) Drug
Figure Global Sales Market Share of Cimzia (certolizumab) Drug by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
